Babel Ventures

Babel Ventures is a Silicon Valley venture capital firm founded in 2017 that invests at the early stage in consumer biotechnology and deep technology companies. The firm describes its remit as backing ventures that address major human challenges, with a stated emphasis on social and environmental impact alongside financial return. In practice it often provides the first venture capital investment a portfolio company receives, positioning it at the seed end of the market rather than as a follow-on investor.

The firm does not publicly disclose fund size or typical check size. Its investment record is characterised instead through reported outcomes: partner Ryan Bethencourt has funded and built more than 70 biotechnology companies, and reported investment returns have reached up to 40x. Portfolio outcomes are stated to range from companies that have gone public to high-return exits, spanning both consumer biotechnology and deep technology.

Babel Ventures operates from Silicon Valley and fields a multidisciplinary team that combines investment experience with biotechnology and entrepreneurial expertise. Its stated approach is to empower visionary founders early in the company-building process, pursuing what it describes as lasting impact and strong financial returns in tandem.

The firm's focus areas include consumer biotechnology, deep technology, and social and environmental impact ventures.